A detailed history of Tower Research Capital LLC (Trc) transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,030 shares of CLSD stock, worth $3,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,030
Previous 15,898 80.94%
Holding current value
$3,120
Previous $20,000 85.0%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.93 - $1.35 $11,967 - $17,371
-12,868 Reduced 80.94%
3,030 $3,000
Q2 2024

Aug 13, 2024

BUY
$1.08 - $1.58 $8,641 - $12,641
8,001 Added 101.32%
15,898 $20,000
Q1 2024

May 15, 2024

SELL
$1.2 - $2.02 $7,338 - $12,352
-6,115 Reduced 43.64%
7,897 $12,000
Q4 2023

Feb 13, 2024

BUY
$0.68 - $1.18 $2,159 - $3,747
3,176 Added 29.31%
14,012 $16,000
Q3 2023

Nov 14, 2023

BUY
$0.82 - $1.27 $8,885 - $13,761
10,836 New
10,836 $9,000
Q1 2023

May 09, 2023

BUY
$0.93 - $1.66 $59 - $106
64 New
64 $0
Q3 2022

Nov 10, 2022

BUY
$1.08 - $1.83 $1,904 - $3,226
1,763 Added 260.41%
2,440 $2,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.49 $9,934 - $19,028
-7,642 Reduced 91.86%
677 $1,000
Q1 2022

May 12, 2022

SELL
$1.35 - $2.88 $5,826 - $12,430
-4,316 Reduced 34.16%
8,319 $19,000
Q4 2021

Feb 14, 2022

BUY
$2.72 - $5.72 $26,351 - $55,415
9,688 Added 328.74%
12,635 $35,000
Q3 2021

Nov 15, 2021

BUY
$4.83 - $7.2 $14,234 - $21,218
2,947 New
2,947 $18,000
Q2 2021

Aug 16, 2021

SELL
$2.32 - $5.38 $38,679 - $89,695
-16,672 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$2.24 - $4.25 $26,754 - $50,762
11,944 Added 252.62%
16,672 $41,000
Q4 2020

Feb 16, 2021

SELL
$1.32 - $2.74 $10,222 - $21,218
-7,744 Reduced 62.09%
4,728 $13,000
Q3 2020

Nov 16, 2020

BUY
$1.45 - $2.0 $16,460 - $22,704
11,352 Added 1013.57%
12,472 $19,000
Q2 2020

Aug 13, 2020

BUY
$1.55 - $2.41 $1,736 - $2,699
1,120 New
1,120 $2,000
Q3 2019

Nov 05, 2019

SELL
$0.59 - $1.32 $4,555 - $10,193
-7,722 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$0.97 - $1.42 $6,643 - $9,725
6,849 Added 784.54%
7,722 $8,000
Q1 2019

May 14, 2019

SELL
$1.1 - $1.74 $4,296 - $6,796
-3,906 Reduced 81.73%
873 $1,000
Q4 2018

Feb 14, 2019

BUY
$1.0 - $6.12 $2,988 - $18,286
2,988 Added 166.83%
4,779 $5,000
Q3 2018

Nov 13, 2018

SELL
$6.03 - $11.24 $32,459 - $60,504
-5,383 Reduced 75.03%
1,791 $11,000
Q2 2018

Aug 15, 2018

SELL
$8.91 - $14.54 $44,558 - $72,714
-5,001 Reduced 41.08%
7,174 $77,000
Q1 2018

May 15, 2018

BUY
$5.57 - $14.28 $67,814 - $173,859
12,175 New
12,175 $130,000
Q4 2017

Feb 09, 2018

SELL
$5.78 - $9.12 $15,999 - $25,244
-2,768 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$6.73 - $8.74 $18,628 - $24,192
2,768
2,768 $24,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $62M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.